OGFRL1 Activators
OGFRL1 Activators are a diverse set of chemical compounds that enhance the functional activity of OGFRL1 through a variety of signaling pathways, each interacting with the biochemical processes that OGFRL1 is directly involved in. Epinephrine and Isoproterenol, by interacting with adrenergic receptors, and Forskolin, through direct stimulation of adenylate cyclase, all increase intracellular cAMP levels. This rise in cAMP activates PKA, which is known to phosphorylate and thus enhance the activity of proteins within the OGFRL1 signaling network. Similarly, IBMX extends the duration of PKA activation by inhibiting the breakdown of cAMP, leading to prolonged enhancement of OGFRL1 activity. PMA's activation of PKC represents another mechanism, which directly phosphorylates proteins that are integral to OGFRL1's function. L-Arginine and Sildenafil, through their contributions to raising nitric oxide and cGMP levels respectively, activate PKG, which may then phosphorylate other substrates that interact with OGFRL1, potentially enhancing its activity.
The activation of OGFRL1 is further influenced by compounds affecting cellular phosphatase and kinase activity. Lithium chloride and Sodium fluoride both act as inhibitors of phosphatases, with the former stabilizing proteins within the Wnt signaling pathway, which may intersect with OGFRL1 signaling, and the latter preventing dephosphorylation events that could otherwise reduce OGFRL1 activity. Anisomycin activates stress-activated protein kinases, which could lead to phosphorylation of substrates within the OGFRL1 pathway, while Roscovitine inhibits cyclin-dependent kinases, potentially leading to upregulation of processes that enhance OGFRL1 activity. Okadaic acid, a potent inhibitor of protein phosphatases, maintains the phosphorylation status of proteins within OGFRL1's signaling pathways, thereby supporting enhanced OGFRL1 activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine engages adrenergic receptors which can stimulate pathways that OGFRL1 is a part of. When these receptors are activated, they trigger a cascade that results in the activation of adenylate cyclase, leading to increased cAMP levels, and subsequently PKA activation. PKA then enhances OGFRL1 activity by phosphorylation of downstream effectors in the signaling pathway. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, leading to an increase in cAMP production. Elevated cAMP activates PKA, which then can phosphorylate substrates that interact with OGFRL1, enhancing its functional activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a synthetic catecholamine that activates beta-adrenergic receptors, leading to the activation of adenylate cyclase and an increase in cAMP. This cascade activates PKA, which can then enhance the activity of OGFRL1 through phosphorylation of related proteins. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP, leading to their accumulation. The increased levels of cAMP can enhance the activity of PKA, resulting in the phosphorylation and activation of targets within the OGFRL1 pathway. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which can phosphorylate and activate certain proteins that are part of the OGFRL1 signaling network, thereby enhancing its activity. | ||||||
L-Arginine | 74-79-3 | sc-391657B sc-391657 sc-391657A sc-391657C sc-391657D | 5 g 25 g 100 g 500 g 1 kg | $20.00 $31.00 $61.00 $219.00 $352.00 | 2 | |
L-Arginine serves as a substrate for nitric oxide synthase, leading to the production of nitric oxide (NO). NO activates guanylate cyclase, increasing cGMP levels, which can then activate PKG. PKG activation might lead to phosphorylation of proteins that interact with OGFRL1, enhancing its function. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits the phosphatase activity of GSK-3. Inhibition of GSK-3 can lead to stabilization and activation of proteins within the Wnt signaling pathway, which may intersect with OGFRL1 signaling pathways, hence enhancing OGFRL1 activity. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $40.00 $46.00 $100.00 | 26 | |
Sodium fluoride is an inhibitor of various phosphatases. By inhibiting dephosphorylation, it can lead to the activation of proteins that interact with the OGFRL1 pathway, enhancing the activity of OGFRL1. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinases (SAPKs). Activation of SAPKs can lead to phosphorylation of substrates that are part of the OGFRL1 signaling pathway, resulting in its enhanced functional activity. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine is an inhibitor of cyclin-dependent kinases (CDKs). By inhibiting CDKs, it may lead to upregulation of cellular processes that enhance the activity of OGFRL1 through phosphorylation of associated proteins. | ||||||